Point72 Asset Management
GMAB icon

Point72 Asset Management’s Genmab GMAB Stock Holding History

Point72 Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-538,500
Closed -$11.1M – 2458
2025
Q2 		$11.1M Sell
538,500
-385,367
-42% -$7.91M 0.02% 693
2025
Q1 		$18.1M Buy
923,867
+835,721
+948% +$17.5M 0.04% 477
2024
Q4 		$1.84M Buy
+88,146
New +$1.94M ﹤0.01% 1277
2024
Q3 		– Sell
-18,184
Closed -$457K – 2123
2024
Q2 		$457K Buy
+18,184
New +$516K ﹤0.01% 1463
2024
Q1 		– Sell
-101,100
Closed -$3.22M – 2335
2023
Q4 		$3.22M Sell
101,100
-177,501
-64% -$5.57M 0.01% 1065
2023
Q3 		$9.83M Buy
278,601
+101,101
+57% +$3.85M 0.03% 665
2023
Q2 		$6.75M Sell
177,500
-83,266
-32% -$3.32M 0.02% 713
2023
Q1 		$9.85M Buy
+260,766
New +$10M 0.03% 551
2021
Q4 		– Sell
-56,600
Closed -$2.47M – 1170
2021
Q3 		$2.47M Sell
56,600
-385,000
-87% -$17.3M 0.01% 769
2021
Q2 		$18M Buy
441,600
+212,900
+93% +$8.22M 0.08% 305
2021
Q1 		$7.51M Buy
+228,700
New +$8.6M 0.04% 492

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's GMAB Position: Q3 2025 in Review

Point72 Asset Management sold out of Genmab (GMAB) in Q3 2025, closing a stake of 538,500 shares — an estimated $11.1M sold.

Point72 Asset Management first reported a position in GMAB in Q1 2021 and held it in 11 quarters. The position peaked at $18.1M in Q1 2025. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Point72 Asset Management reported no remaining Genmab position as of Q3 2025 after selling out during the quarter.
  • Point72 Asset Management sold 538,500 Genmab shares in Q3 2025, an estimated $11.1M.
  • Point72 Asset Management first reported a position in Genmab in Q1 2021 and held it in 11 quarters.
  • Point72 Asset Management's Genmab position peaked at $18.1M in Q1 2025.
  • 252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Point72 Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.